HPC-1/syntaxin 1A gene knockout mice show abnormal behavior possibly related to a disruption in 5-HTergic systems

European Journal of Neuroscience

Volumn 32, Issue 1, 2010, Pages 99-107

  Fujiwara, Tomonori ^a   Snada, Masumi ^a   Kofuji, Takefumi ^a   Yoshikawa, Takeo ^b   Akagawa, Kimio ^a  

^a KYORIN UNIVERSITY   (Japan)

^b RIKEN BRAIN SCIENCE INSTITUTE   (Japan)

Author keywords

behavior; HPC 1 syntaxin 1A; knockout mice; presynaptic mechanisms; serotonergic system; SNARE proteins

Indexed keywords

1 [2 (BENZHYDRYLOXY)ETHYL] 4 (3 PHENYLPROPYL)PIPERAZINE; 2 DIPROPYLAMINO 7 HYDROXYTETRALIN; 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 4 IODO 2,5 DIMETHOXYAMPHETAMINE; FLUOXETINE; HALOPERIDOL; QUINPIROLE; SEROTONIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG INHIBITION; GENE; GENE MUTATION; HETEROZYGOSITY; HIPPOCAMPUS; HOMOZYGOSITY; HYPOTHALAMUS; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SCHIZOPHRENIA; SOCIAL INTERACTION; STX1A GENE;

2,3,4,5-TETRAHYDRO-7,8-DIHYDROXY-1-PHENYL-1H-3-BENZAZEPINE; 8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN; ADRENERGIC UPTAKE INHIBITORS; AMPHETAMINES; ANIMALS; BEHAVIOR, ANIMAL; DESIPRAMINE; DOPAMINE AGONISTS; DOPAMINE ANTAGONISTS; FLUOXETINE; HALOPERIDOL; HIPPOCAMPUS; HUMANS; HYPOTHALAMUS; INHIBITION (PSYCHOLOGY); MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PHENOTYPE; PIPERAZINES; QUINPIROLE; RECEPTOR, SEROTONIN, 5-HT2A; SEROTONIN; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SEROTONIN RECEPTOR AGONISTS; SEROTONIN UPTAKE INHIBITORS; SOCIAL BEHAVIOR; SYNTAXIN 1;

EID: 77954410184     PISSN: 0953816X     EISSN: 14609568     Source Type: Journal    
DOI: 10.1111/j.1460-9568.2010.07269.x     Document Type: Article

References (40)

1. Ase, A.R., Reader, T.A., Hen, R., Riad, M. Descarries, L. (2001) Regional changes in density of serotonin transporter in the brain of 5-HT1A and 5-HT1B knockout mice, and of serotonin innervation in the 5-HT1B knockout. J. Neurochem., 78, 619 630.
2. Bakshi, V.P., Swerdlow, N.R. Geyer, M.A. (1994) Clozapine antagonizes phencyclidine-induced deficits in sensorimotor gating of the startle response. J. Pharmacol. Exp. Ther., 271, 787 794.
3. Beasley, C.L., Honer, W.G., Bergmann, K., Falkai, P., Lütjohann, D. Bayer, T.A. (2005) Reductions in cholesterol and synaptic markers in association cortex in mood disorders. Bipolar Disord, 7, 449 455.
4. Bevins, R.A. Besheer, J. (2006) Object recognition in rats and mice: a one-trial non-matching-to-sample learning task to study 'recognition memory'. Nat Protoc, 1, 1306 1311.
5. Blier, P. Szabo, S.T. (2005) Potential mechanisms of action of atypical antipsychotic medications in treatment-resistant depression and anxiety. J Clin Psychiatry Suppl, 8, 30 40.
6. Brose, N. (2008) Altered Complexin expression in psychiatric and neurological disorders: cause or consequence? Mol Cells, 25, 7 19.
7. Bursch, B., Ingman, K., Vitti, L., Hyman, P. Zeltzer, L.K. (2004) Chronic pain in individuals with previously undiagnosed autistic spectrum disorders. J Pain, 5, 290 295.
8. Feng, Y., Crosbie, J., Wigg, K., Pathare, T., Ickowicz, A., Schachar, R., Tannock, R., Roberts, W., Malone, M., Swanson, J., Kennedy, J.L. Barr, C.L. (2005) The SNAP25 gene as a susceptibility gene contributing to attention-deficit hyperactivity disorder. Mol Psychiatry, 10, 998 1005.
9. Fujiwara, T., Yamamori, T. Akagawa, K. (2001) Suppression of transmitter release by Tat HPC-1/syntaxin 1A fusion protein. Biochim. Biophys. Acta, 1539, 225 232.
10. Fujiwara, T., Mishima, T., Kofuji, T., Chiba, T., Tanaka, K., Yamamoto, A. Akagawa, K. (2006) Analysis of knock-out mice to determine the role of HPC-1/syntaxin 1A in expressing synaptic plasticity. J. Neurosci., 26, 5767 5776.
11. Gainetdinov, R.R., Wetsel, W.C., Jones, S.R., Levin, E.D., Jaber, M. Caron, M.G. (1999) Role of serotonin in the paradoxical calming effect of psychostimulants on hyperactivity. Science, 283, 397 401.
12. Geyer, M.A., McIlwain, K.L. Paylor, R. (2002) Mouse genetic models for prepulse inhibition: an early review. Mol Psychiatry, 7, 1039 1053.
13. Gillberg, C. (2003) Deficits in attention, motor control, and perception: a brief review. Arch. Dis. Child., 88, 904 910.
14. Gomot, M., Giard, M.H., Adrien, J.L., Barthelemy, C. Bruneau, N. (2002) Hypersensitivity to acoustic change in children with autism: electrophysiological evidence of left frontal cortex dysfunctioning. Psychophysiology, 39, 577 584.
15. Harrell, A.V. Allan, A.M. (2003) Improvements in hippocampal-dependent learning and decremental attention in 5-HT(3) receptor overexpressing mice. Learn Mem, 10, 410 419.
16. Huang, Y.Y. Kandel, E.R. (2007) 5-Hydroxytryptamine induces a protein kinase A/mitogen-activated protein kinase-mediated and macromolecular synthesis-dependent late phase of long-term potentiation in the amygdala. J. Neurosci., 27, 3111 3119.
17. Inoue, A., Obata, K. Akagawa, K. (1992) Cloning and sequence analysis of cDNA for a neuronal cell membrane antigen, HPC-1. J. Biol. Chem., 267, 10613 10619.
18. Jahn, R. Hanson, P.I. (1998) Membrane fusion. SNAREs line up in new environment. Nature, 393, 14 15.
19. Kilts, C.D. (2001) The changing roles and targets for animal models of schizophrenia. Biol. Psychiatry, 50, 845 855.
20. Koh, S., Yamamoto, A., Inoue, A., Inoue, Y., Akagawa, K., Kawamura, Y., Kawamoto, K. Tashiro, Y. (1993) Immunoelectron microscopic localization of the HPC-1 antigen in rat cerebellum. J. Neurocytol., 22, 995 1005.
21. Kolevzon, A., Mathewson, K.A. Hollander, E. (2006) Selective serotonin reuptake inhibitors in autism: a review of efficacy and tolerability. J. Clin. Psychiatry, 67, 407 414.
22. Lubow, R.E. (2005) Construct validity of the animal latent inhibition model of selective attention deficits in schizophrenia. Schizophr. Bull., 31, 139 153.
23. Meyer-Lindenberg, A., Mervis, C.B. Berman, K.F. (2006) Neural mechanisms in Williams syndrome: a unique window to genetic influences on cognition and behaviour. Nat Rev Neurosci, 7, 380 393.
24. Miyamoto, Y., Yamada, K., Noda, Y., Mori, H., Mishina, M. Nabeshima, T. (2001) Hyperfunction of dopaminergic and serotonergic neuronal systems in mice lacking the NMDA receptor epsilon1 subunit. J. Neurosci., 21, 750 757.
25. Moser, P.C., Hitchcock, J.M., Lister, S. Moran, P.M. (2000) The pharmacology of latent inhibition as an animal model of schizophrenia. Brain Res. Brain Res. Rev., 33, 275 307.
26. Nakamura, K., Anitha, A., Yamada, K., Tsujii, M., Iwayama, Y., Hattori, E., Toyota, T., Suda, S., Takei, N., Iwata, Y., Suzuki, K., Matsuzaki, H., Kawai, M., Sekine, Y., Tsuchiya, K.J., Sugihara, G., Ouchi, Y., Sugiyama, T., Yoshikawa, T. Mori, N. (2008) Genetic and expression analyses reveal elevated expression of syntaxin 1A (STX1A) in high functioning autism. Int J Neuropsychopharmacol., 11, 1073 1084.
27. Nakayama, T., Matsuoka, R., Kimura, M., Hirota, H., Mikoshiba, K., Shimizu, Y., Shimizu, N. Akagawa, K. (1998) Hemizygous deletion of the HPC-1/syntaxin 1A gene (STX1A) in patients with Williams syndrome. Cytogenet. Cell Genet., 82, 49 51.
28. van Raamsdonk, J.M., Pearson, J., Slow, E.J., Hossain, S.M., Leavitt, B.R. Hayden, M.R. (2005) Cognitive dysfunction precedes neuropathology and motor abnormalities in the YAC128 mouse model of Huntington's disease. J. Neurosci., 25, 4169 4180.
29. Radulovic, J., Kammermeier, J. Spiess, J. (1998) Relationship between fos production and classical fear conditioning: effects of novelty, latent inhibition, and unconditioned stimulus preexposure. J. Neurosci., 18, 7452 7461.
30. Rizk, A., Curley, J., Robertson, J. Raber, J. (2004) Anxiety and cognition in histamine H3 receptor-/- mice. Eur. J. Neurosci., 19, 1992 1996.
31. Rubenstein, J.L. Merzenich, M.M. (2003) Model of autism: increased ratio of excitation/inhibition in key neural systems. Genes Brain Behav, 2, 255 267.
32. Samuvel, D.J., Jayanthi, L.D., Bhat, N.R. Ramamoorthy, S. (2005) A role for p38 mitogen-activated protein kinase in the regulation of the serotonin transporter: evidence for distinct cellular mechanisms involved in transporter surface expression. J. Neurosci., 25, 29 41.
33. Shakesby, A.C., Anwyl, R. Rowan, M.J. (2002) Overcoming the effects of stress on synaptic plasticity in the intact hippocampus: rapid actions of serotonergic and antidepressant agents. J. Neurosci., 22, 3638 3644.
34. Silver, H. (2003) Selective serotonin reuptake inhibitor augmentation in the treatment of negative symptoms of schizophrenia. Int. Clin. Psychopharmacol., 18, 305 313.
35. Südhof, T.C. (1995) The synaptic vesicle cycle: a cascade of protein-protein interactions. Nature, 375, 645 653.
36. Takasusuki, T., Fujiwara, T., Yamaguchi, S., Fukushima, T., Akagawa, K. Hori, Y. (2007) Enhancement of synaptic transmission and nociceptive behaviour in HPC-1/syntaxin 1A knockout mice following peripheral nerve injury. Eur. J. Neurosci., 26, 2179 2187.
37. Tang, Y.P., Shimizu, E., Dube, G.R., Rampon, C., Kerchner, G.A., Zhuo, M., Liu, G. Tsien, J.Z. (1999) Genetic enhancement of learning and memory in mice. Nature, 401, 63 69.
38. Winslow, J.T. Insel, T.R. (2002) The social deficits of the oxytocin knockout mouse. Neuropeptides, 36, 221 229.
39. Wong, A.H., Trakalo, J., Likhodi, O., Yusuf, M., Macedo, A., Azevedo, M.H., Klempan, T., Pato, M.T., Honer, W.G., Pato, C.N., Van Tol, H.H. Kennedy, J.L. (2004) Association between schizophrenia and the syntaxin 1A gene. Biol. Psychiatry, 56, 24 29.
40. Young, A.M., Moran, P.M. Joseph, M.H. (2005) The role of dopamine in conditioning and latent inhibition: what, when, where and how? Neurosci. Biobehav. Rev., 29, 963 976.